Literature DB >> 13657801

Oral hypoglycaemic drugs.

J D SLATER.   

Abstract

Keywords:  ANTIDIABETICS/therapeutic use

Mesh:

Substances:

Year:  1959        PMID: 13657801      PMCID: PMC2501957          DOI: 10.1136/pgmj.35.403.248

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  43 in total

1.  Pharmacological studies of a new oral hypoglycemic drug.

Authors:  G UNGAR; L FREEDMAN; S L SHAPIRO
Journal:  Proc Soc Exp Biol Med       Date:  1957-05

2.  Carbutamide and plasma insulin activity.

Authors:  C VON HOLT; L VON HOLT; J KRACHT; B KRONER; J KUHNAU
Journal:  Science       Date:  1957-04-19       Impact factor: 47.728

3.  Further experience with the use of sulfonylureas in diabetes.

Authors:  S B BEASER
Journal:  Ann N Y Acad Sci       Date:  1957-07-10       Impact factor: 5.691

4.  Use of the sulfonylureas in diabetes mellitus.

Authors:  S J SUGAR
Journal:  Ann N Y Acad Sci       Date:  1957-07-10       Impact factor: 5.691

5.  Pharmacology and mode of action of the sulphonylureas in man.

Authors:  J M STOWERS; R F MAHLER; R B HUNTER
Journal:  Lancet       Date:  1958-02-08       Impact factor: 79.321

6.  Role of insulin in acute hypoglycaemic action of tolbutamide.

Authors:  J A WEAVER; T E PROUT; G W SCOTT; S P ASPER
Journal:  Br Med J       Date:  1958-02-22

7.  Acute effects of orinase on peripheral glucose utilization.

Authors:  A S GILBERTSEN; F C GOETZ; V JOSEPHSON
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

8.  Observations on the action of certain sulfonylurea derivatives.

Authors:  J BERTHET; M H MAKMAN; E W SUTHERLAND
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

9.  Some effects of orinase in the rat.

Authors:  S LANG; S SHERRY
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

10.  In vitro studies on the action of sulfonamide hypoglycemic agents.

Authors:  M VAUGHAN
Journal:  Science       Date:  1956-05-18       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.